Introduction
Methicillin-resistant staphylococci are the most common cause of antibiotic-resistant healthcare-associated infections in hospitals worldwide. 1 Methicillin-resistant staphylococci, particularly Staphylococcus aureus (MRSA), are now recognized as the main pathogens of nosocomial bacterima associated with orthopedic equipment colonization and intravascular catheter as well as postoperative infections in general. Over the past few decades, MRSA strains have become not only resistant to beta-lactam antibiotics, but also acquired additional resistance to non-beta-lactam antibiotics, including aminoglycosides. 2, 3 Tobramycin and gentamicin are the most efficient aminoglycosides against MRSA which are commonly used in combination with other types of antibiotics, especially in the treatment of staphylococcal endocarditis. 3 Enzymatic modification of aminoglycosides is the most frequently encountered mechanism of resistance to aminoglycosides in staphylococci, which is predominantly mediated by five groups: aminoglycoside-6′-N- 4 Clinically, the most important of these enzymes are ANT (4´)-I, AAC (6´)/APH(2′′) and APH (3´)-III because these enzymes modify aminoglycosides of therapeutic significance, including tobramycin, gentamicin and kanamycin, respectively. 4, 5 Many of these modifying enzymes are carried on the transposons or on small plasmids and can be integrated into the staphylococcal chromosomal cassette mec (SCCmec) of Staphylococcus aureus and coagulase negative staphylococci isolates. 3, 4 In this study, we investigated the distribution of the most clinically significant aminoglycoside resistance genes ant (4´)-Ia, aac(6′)/ aph(2′′) and aph(3´)-IIIa, as well as the distribution of staphylococcal cassette chromosome mec (SCCmec) types, among meticillin-resistant Staphylococcus aureus isolates from two university hospitals in Zanjan, Iran.
Materials and methods

Chemicals and reagents
All experiments were performed with chemicals in analytical-reagent grade. PCR Master Mix (2X) was obtained from Fermentas (Waltham, USA). Primers were purchased from Generay Biotech (Shanghai, China). Ethanol, Tris, EDTA, phenol/chloroform and other chemicals were obtained from Merck (Darmstadt, Germany).
Bacterial isolates
In current research, nasal specimens were collected between November 2011 and February 2012 from health care workers (HCW) of two university-affiliated hospitals in Zanjan, Iran. Study participants were 260 HCW who were working in various departments of the hospitals. Nasal samples were collected from nostrils with collection swabs, and directly streaked on mannitol salt agar, then incubated at 37˚C for 24 h in order to isolate the specimens. Initial identification was further done using conventional methods, including Gram staining, colony morphology, slide coagulation test and catalase test, and further confirmatory test was done by amplification of the species-specific primer for Sa442 and femA genes. 6, 7 Nucleotide sequences belonging to primers used in this investigation are shown in Table 1 . For this purpose, staphylococcal DNA was extracted using the phenol/chloroform method and used as templates; DNA extractions were stored at −20˚C until use. 8 The presence of the mecA gene was investigated by PCR method using a set of previously described primers. 9 
Antimicrobial susceptibility testing
The phenotypic resistance to various antibiotics in MRSA isolates was determined using the standard disk diffusion Multiplex PCR All MRSA isolates were investigated by multiplex PCR strategy to determine staphylococcal cassette chromosome mec types and subtypes (SCCmec), according to previously described methods. 11 In addition, three sets of primers specific for ant(4′)-Ia, aac(6′)/aph(2′′) and aph(3′)-IIIa were chosen from published sequences. 12, 13 All MRSA isolates were analyzed by polymerase chain reaction (PCR) with a PCR master mix (Fermentas, K01071) containing 500 ng genomic DNA, 20 pM primer mix (10 pM for each primer), and distilled water to a final volume of 25 µL. Negative and positive controls were also included in PCR assays. The reaction was carried out in a thermocycler (iCycler, BIO-RAD, USA) according to the following program: 94˚C for 5 min; 35 cycles of 94˚C for 1 minute, 55˚C for 45 s, 72˚C for 40 s; and a final extension at 72˚C for 7 min. After amplification, PCR products were subjected to electrophoresis in 1.5% agarose. The gels were then stained with DNA robust staining dye (SyberGreen) and photographed under UV light.
Results
Among the 260 nasal swabs obtained from HCW, 104 of the isolates were identified as S. aureus through biochemical procedures. All the 104 isolates were Sa442 and femA positive (implying they were S. aureus), and the mecA gene (encoding PBP2a, a penicillin-binding protein that mediate meticillin resistance) was found in 58 of the 104 staphylococcal isolates based on PCR analysis (Fig.  1) . 7 These high rates of MRSA isolates are comparable with other reports that show similar rates.
14 All 58 MRSA isolates were sensitive to vancomycin; conversely, phenotypic resistance patterns of the strains to aminoglycosides were as follows: 96.4% to penicillin G, 98.3% to oxacilin, 53.4% to erythromycin, 55.2% to clindamycin, 51.7% to gentamicin, 58.6% to tobramycin, and 62% to kanamycin. The rates of prevalence of AME gene were as follows: aac(6′)/aph(2′′), 48.3 %; ant(4′)-Ia, 24%; and the aph(3′)-Ia gene was the least frequent AME gene among MRSA isolates (19%). Thirty-four (57%) isolates carried one of these genes either alone or in combination with other genes (Fig. 2) .
Two resistance genes of aac(6′)/aph(2′′) and aph(3´)-III
were simultaneously presented in 9 (15.5%) of the isolates.
Ant (4′)-Ia and aac(6′)/aph(2′′) genes coexisted in 7 (12%) of the MRSA isolates. The triple combination of ant (4´)-I, aac(6´)-aph(2′′)
and aph(3´)-III was determined in 3.4% of the isolates, and among these MRSA strains 37 (64%) isolates had at least one of these genes. In the present study, 5 
Discussion
Antibiotic resistance is a major problem in the world. [14] [15] [16] [17] A wide distribution of the mecA gene and AMEs genes in S. aureus has been demonstrated in previous studies. The current investigation also demonstrated the prevalence of the SCCmec types and subtypes along with the most clinically important aminoglycoside resistance genes in MRSA isolates. The mecA gene was detected in 58 of the 104 staphylococcal specimens. Among the mecA -positive isolates there was one Staphylococcus isolate which was not phenotypically sensitive to oxacillin, revealing again that the exhibition of different phenotypical and genotypical profiles is possible. In the present study, maximum resistance of MRSA isolates was observed towards oxacillin and penicillin G followed by kanamycin, tobramycin, clindamycin, erythromycin, and gentamicin. Nearly 76% of our isolates were resistant to at least four or more antimicrobial agents tested; namely, oxacillin, penicillin G, erythromycin, clindamycin, and three of which were aminoglycosides. Aminoglycosides have been used in the treatment of staphylococcal infections, but emergence of the resistant strains, mostly caused by AMEs, reduce their effectiveness. The aac(6′)/aph(2′′) gene, conferring gentamicin resistance, was determined in 48% of our methicillinresistant isolates followed by the ant(4)-Ia and aph(3´)-IIIa genes, respectively. These results are in accordance with previous studies which reported that prevalence of aac(6′)/aph(2′′) gene is higher than that of two other AME genes, ant(4′)-Ia and aph(3′)-IIIa, in MRSA isolates. 12, 14 Our results showed a correlation between the presence of aac(6′)/aph(2′′) gene and gentamicin resistance. Of 30 isolates which were susceptible to gentamicin resistance determined by the disk diffusion method, only two strains were negative for the presence of aac(6´)/aph(2′′) gene. The prevalence rate of aac(6′)/aph(2′′) gene in this study (48%) was significantly lower than the rate reported from two hospitals in the capital city, Tehran, 18 (i.e., 83%) and higher than a report from Turkey 14 (i.e., 28%). These conflicting findings can be caused by changes in antibiotic policies. The second most frequent AME detected in this research was ant (4′)-Ia, which conferred resistance to kanamycin and was in agreement with the report from Tehran, Iran. 18 The majority of the isolates carrying this gene (83%) were also resistant to kanamycin. 14 We detected the resistance gene aph (3′)-IIIa in 11 (19%) of our isolates; The 82% of these isolates harbored aac(6′)/aph(2″) in combination. Sixty-seven percents of isolates negative for AME genes were susceptible to all aminoglycosides tested. In the present study, 62% of MRSA isolates carry one SCCmec types I, II or III, which are traditionally associated with HA-MRSA. According to the previous studies which have reported that isolates containing HA-MRSA harbor more resistance genes than other SCCmec types, our data showed that isolates with SCCmec III were more resistant to non beta-lactam antibiotics such as ciprofloxacin, clindamycin and erythromycin, but the differences were not statistically significant for all antibiotics (Table 1) . 15, 19 The SCCmec type V and IVa were the most prevalent types identified among community-associated MRSA (CA-MRSA), which accounted for 31% and 29.3% of the isolates. The data shows the tendency of SCCmec types V and IVa strains, the smallest structural types, to transmit in healthcare facilities as mentioned previously.
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Conclusion
In summary, in this study a high level of resistance of MRSA to multiple classes of antibiotics and upward trend in emergence of CA-MRSA strains in hospitals was observed. Introduction of CA-MRSA strains in hospitals and other health care settings has become a threat to public health. In order to prevent transmission of these CA-MRSA strains, accurate and rapid monitoring techniques should be administered in both clinical and community settings. 
